News & AnalysisSporos Bioventures takes in $38.1m Series ASporos Bioventures, a new biotech company, has secured $38.1 million in Series A financing.ByIris Dorbian6 May 2021•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsHealthcareBriefs